Investor Presentation

AI summary - Q2FY27 revenue 1,143 mn INR +28% y-y, EBITDA 407 mn +21% y-y, PAT 356 mn -3% y-y - Revenue growth driven by higher volumes; new plants ramping up; onsite plant East India full revenue from Q3FY27 - Gases segment revenue up 28% y-y; margin 39% in Q2FY27, slight sequential dip due to transport and salary costs - Won 4,807 mn INR BHEL order for 1,200 TPD cryogenic ASU plant; key for coal-to-ammonium nitrate project - Capex guidance: 2,500 mn INR FY27, 2,000 mn INR FY28; plans for solar capacity additions ongoing - Growth strategy includes expanding onsite supply, automating packaging, strategic acquisitions, and product diversification - Industry expected to grow ~7.5% CAGR through 2028, driven by steel, chemicals, healthcare, pharma sectors - Strong balance sheet with 4,240 mn INR cash, ROCE 17%, ROE 14% - Multiple plants commissioned and ramping; new merchant plants planned for FY28 - Price increases to offset freight cost hikes under negotiation, expected in next quarters